Home » News » Professor Ponnusamy Saravanan appointed as new editor-in-chief for Clinical Medicine

Professor Ponnusamy Saravanan appointed as new editor-in-chief for Clinical Medicine

Professor Ponnusamy Saravanan has been appointed as the next editor-in-chief of the RCP’s oldest journal, Clinical Medicine (ClinMed). He will take over from Professor Anton Emmanuel in January 2024 to lead the ClinMed editorial board and strategically move the journal forward.

Professor Saravanan is a professor and honorary consultant physician in diabetes, endocrinology and metabolism at Warwick Medical School, University of Warwick and George Eliot Hospital, Nuneaton. He is the lead for the diabetes division for the NIHR Clinical Research Network, West Midlands. He is the founder-director of the international Doctoral Training Programme, which focuses on research capacity-building activities in low- and middle-income countries.

He splits his time equally between clinical and research activity. For the past 17 years, Prof Saravanan’s main research focus is understanding the mechanisms and ethnic variations in ‘programming of obesity and cardiometabolic disorders’ as well as ‘precision medicine’. He has published >130 peer-reviewed articles and won several national and international awards. He passionately believes in ‘primordial prevention’ of metabolic disorders and approaches this by focusing on the health of young women and gestational diabetes (GDM). To address this, he has set up early pregnancy cohorts across the world (UK – PRiDE study, n=4,746; STRiDE – India, n=3,070; STRiDE – Kenya, n=4,134; Malaysia – MAGIC, n=5,200 and Thailand – TaRGET, n=4,260).

His team won the prestigious NHS Innovation award in 2015 for individualised diabetes management for South Asians in the UK. He is instrumental in fast-track adoption of newer therapies and technologies in diabetes locally, regionally and nationally. During the COVID-19 pandemic he was instrumental in writing the new RCOG UK screening guidelines for GDM based on his work, which were adopted widely in the UK. He co-led the BABYSTEPS trial – an innovative, combined face-to-face and remote intervention in post-GDM women to improve their physical activity, in collaboration with University of Leicester. He served as an associate editor for many journals prior to taking the role of editor-in-chief for the RCP’s journal Clinical Medicine. He reviews grants and is a board member for funding bodies nationally and internationally.

Prof Saravanan said:

‘I am absolutely thrilled to embark on the exciting journey as the editor-in-chief for the RCP's journal Clinical Medicine. I am enthusiastic about steering ClinMed into a new era of medical publishing.

My vision is crystal clear: I aim to establish ClinMed as the go-to destination for top-notch publications from global researchers and clinicians. These contributions will not only educate but also revolutionize clinical practices in the field of medicine. Embracing the dynamic landscape of medical publishing, we'll leverage the power of social media and artificial intelligence. Picture this: multimedia enhancements, swift turnaround times and skills development opportunities for our authors, all while upholding the pillars of transparency and high-quality governance.

While elevating ClinMed is my primary focus, I am equally ambitious about collaborating with the senior management team to align ClinMed with RCP's global priorities. Together, we will position ClinMed as the resounding voice and advocate for the RCP worldwide. Join me in this transformative journey as we redefine the standards of medical publishing and make an indelible mark on the world of healthcare.’

We congratulate Prof Saravanan on his appointment and look forward to working with him and the wider journals team. Professor Emmanuel will remain at the RCP as medical director of publishing, overseeing Clinical Medicine, Future Healthcare Journal and Commentary.